Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2000
08/31/2000CA2364754A1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2000CA2364749A1 6-substituted-7-heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2000CA2364130A1 Tumor necrosis factor antagonists for the treatment of neurological disorders
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363601A1 Carbohydrate epitope mimic peptides and uses thereof
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/31/2000CA2361401A1 Transplantation of haematopoietic cells
08/31/2000CA2333955A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
08/30/2000EP1031349A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030857A2 Adenosine a1 receptor agonists
08/30/2000EP1030856A2 Adenosine a1 receptor agonists
08/30/2000EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030842A1 Metalloproteinase inhibitors
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP1030672A1 Method for treating attention deficit disorder
08/30/2000EP1030671A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
08/30/2000EP1030667A1 Use of mirtazapine for treating sleep apneas
08/30/2000EP0836606B1 Condensed thiazole derivatives, having 5-ht receptor affinity
08/30/2000EP0690843B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity
08/30/2000EP0584290B1 Endothelin antagonists
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/30/2000CN1265108A 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their prepn. and their application in therapy
08/30/2000CN1265106A Compounds derived from thophene and benzothiophene, and related utilisation and compsn.
08/30/2000CN1265101A Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
08/30/2000CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn.
08/30/2000CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides
08/30/2000CN1264704A Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same
08/30/2000CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same
08/30/2000CN1055837C Chinese medicine for treating blood vessel dementia
08/30/2000CN1055836C Fresh-juice Tianmami (gastrodia tuber sweet) health care food and making method thereof
08/30/2000CN1055835C Lianhuangsong pill and capsule and its prepn. method
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6110973 Methods for treating obesity and weight gain using optically pure (-)-bupropion
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110961 Phenoxathin derivatives as inhibitors of monoamine oxidase
08/29/2000US6110956 N-aryloxyethylamine derivatives for the treatment of depression
08/29/2000US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110940 Salts of an anti-migraine indole derivative
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
08/29/2000US6110935 A promoter for n-methyl-d-aspartic acid (nmda) receptors, useful for such therapeutic purposes as facilitating the learning of behaviors, treating schizophrenia, memory impairment
08/29/2000US6110919 Diazabicyclic neurokinin antagonists
08/29/2000US6110918 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist
08/29/2000US6110917 Selective serotonin (5-ht) receptor agonist for treating migraines, vasospasms
08/29/2000US6110914 Spiroazabicyclic heterocyclic compounds
08/29/2000US6110896 Peptidyl compounds and their therapeutic use
08/29/2000US6110894 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
08/29/2000US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
08/29/2000US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN)
08/29/2000US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
08/29/2000US6110460 Methods of using morphogen analogs
08/29/2000CA2016631C Substituted aminoalkylphosphinic acids
08/29/2000CA2012628C New fluoro-4 benzoic derivatives, process for their preparation and pharmaceutical compositions containing them
08/24/2000WO2000049160A1 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders
08/24/2000WO2000049144A2 Pyk2 binding proteins
08/24/2000WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell
08/24/2000WO2000049135A2 Substrate for cell growth
08/24/2000WO2000049043A2 Human lipid-associated proteins
08/24/2000WO2000049017A1 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
08/24/2000WO2000049000A1 Dopamine d1 receptor agonist compounds
08/24/2000WO2000048999A1 Morphan derivatives or salts thereof and medicinal compositions containing the same
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048988A1 Phenylalaninol derivatives
08/24/2000WO2000048987A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048639A1 Immobilized labeling compounds and methods
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048621A2 Methods and compositions for regulating protein-protein interactions
08/24/2000WO2000048608A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb¿1?
08/24/2000WO2000048600A1 Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
08/24/2000WO2000048599A1 Use of desoxypeganine in the treatment of alzheimer's dementia
08/24/2000WO2000048586A1 Remedies
08/24/2000WO2000048584A2 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
08/24/2000WO2000048582A2 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
08/24/2000WO2000048579A1 Desoxypeganine transdermal therapeutic system
08/24/2000WO2000048572A1 Phosphocholine linked prodrug derivatives
08/24/2000WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions
08/24/2000WO2000048549A2 Anticonvulsant derivatives useful in treating essential tremor
08/24/2000WO2000048446A2 Use of antagonists of pg-e for the treatment of neuropathic pain
08/24/2000WO2000048445A2 Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
08/24/2000WO2000029550A3 Low oxygen culturing of central nervous system progenitor cells
08/24/2000WO2000025138A3 Methods of diagnosing or prognosing alzheimer's disease
08/24/2000WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
08/24/2000WO2000023571A3 A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
08/24/2000WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000018917A9 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
08/24/2000WO2000016800A9 Methods of treating chronic pain
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000015205A3 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
08/24/2000WO2000012685A3 Genes associated with neurotransmitter processing
08/24/2000WO2000010611A3 Drug targeting
1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 1833